Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implants Create Niche for Fungi and Bacteria

By HospiMedica International staff writers
Posted on 17 Jul 2018
A new study reveals that implants provide a distinct alcove for microbial colonization, but that the most prevalent microbes are not those responsible for implant infections.

Researchers at the University of Copenhagen (KU; Denmark), Rigshopitalet University Hospital (Copenhagen, Denmark), the Georgia Institute of Technology (Atlanta, USA), and other institutions conducted a study of 106 implants (ranging from screws and knees to pacemakers) surrounding tissues in four groups (aseptic loosening, healed fractures, craniofacial complications, and the recently deceased) in five different hospitals in the Capital region of Denmark. More...
The aim of the study was to detect and identify implant microbiomes from patients with no prior indications of implant-related infections.

The researchers also made 39 controls to ensure the implants were not contaminated during collection or subsequent analysis. This was done by opening a sterile implant in the laboratory, during surgery or an implant removed shortly after placement. The results revealed 78 implants (70%) were colonized by bacteria, fungi or both. A significant majority of screws were colonized by bacteria, but the prevalence of fungi was the same for all implants. None of the bacteria or fungi detected were pathogens, none of the patients showed signs of infection, and all controls were negative. The study was published on July 2, 2018, in APMIS.

“We have always believed implants to be completely sterile. It is easy to imagine, though, that when you insert a foreign body into the body, you create a new niche, a new habitat for bacteria. The question is whether this is beneficial, like the rest of our microbiome, whether they are precursors to infection, or whether it is insignificant,” said senior author Professor Thomas Bjarnsholt, PhD, of the KU department of immunology and microbiology. “This opens up a brand new field and understanding of the interplay between the body and bacteria and microbiomes.”

“It is important to stress that we have found no direct pathogens, which normally cause infection. Of course if they had been present, we would also have found an infection,” concluded lead author Tim Holm Jakobsen, PHd, of Rigshopitalet. “The study shows a prevalence of bacteria in places where we do not expect to find any, and they manage to remain there for a very long time, probably without affecting the patient negatively.”

Related Links:
University of Copenhagen
Rigshopitalet University Hospital
Georgia Institute of Technology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.